Biogen | BIIB - 流动资产



金融业
股票价格
USD
资产
USD 29.48B
现金及等价物
USD 3.38B
销售成本
USD 797.5M
流动资产
USD 9.19B
流动负债
USD 3B
债务
USD 6.56B
EBIT
USD 514.3M
EBITDA
USD 649.7M
员工
7.61K
EPS每股收益
USD 3.57
股本和储备
USD 18.65B
销售毛利
USD 1.82B
债务利息支出
USD 72.6M
利息收入
USD 37.9M
贷款资金
USD 6.29B
市值
USD 31.25B
净收入
USD 319.5M
营业费用
USD 1.96B
营业利润
USD 514.3M
普通股股本
USD 146.7M
PE价格收益
13.7
税前利润
USD 377.7M
销售收入
USD 2.25B
销售和管理费用
USD 554.3M
股票
USD 1.95B
贸易债权人
USD 358.5M
应收帐款人
USD 1.79B


流动资产 更改 日
AbbVie USD 33.53B 4.47B 2026-03
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
ALKERMES USD 1.36B 570.52M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Incyte USD 5.48B 460.36M 2026-03
Merck USD 35.02B 8.5B 2026-03
Moderna USD 5.77B 774M 2026-03
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.16B 789M 2026-03
Sanofi EUR 30.95B 8.99B 2025-12
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03